China Medical System Holdings Limited (HKG:0867)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
10.92
-0.07 (-0.64%)
Sep 2, 2026, 9:40 AM HKT

HKG:0867 Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, HKG:0867 stock has a consensus rating of "Strong Buy" and an average price target of $17.78. The average 1-year stock price forecast is 62.82% higher than the current stock price, while the lowest is $14.62 (+33.88%) and the highest is $20.13 (+84.34%).

Price Target: $17.78 (+62.82%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$14.62$17.78$17.53$20.13
Change+33.88%+62.82%+60.53%+84.34%

Analyst Ratings

The average analyst rating for HKG:0867 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26Jun '26Jul '26Aug '26
Strong Buy876878
Buy111111
Hold111111
Sell000000
Strong Sell000000
Total109810910

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
TFI Asset Management
No rating
TFI Asset Management
Buy
Maintains
$19.17
BuyMaintains$19.17+75.55%Aug 29, 2026
Unknown Analyst
Citic Securities
No rating
Citic Securities
Buy
Maintains
$19.00
BuyMaintains$19.00+73.99%Aug 26, 2026
Unknown Analyst
First Shanghai Securities
No rating
First Shanghai Securities
Buy
Maintains
$15.90
BuyMaintains$15.90+45.60%Aug 25, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$17.50
BuyMaintains$17.50+60.26%Aug 20, 2026
Unknown Analyst
Citi
No rating
Citi
Buy
Maintains
$17.50
BuyMaintains$17.50+60.26%Aug 20, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
9.61B
from 8.21B
Increased by 17.02%
Revenue Next Year
11.56B
from 9.61B
Increased by 20.25%
EPS This Year
0.87
from 0.73
Increased by 18.56%
EPS Next Year
0.97
from 0.87
Increased by 11.65%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
8.34B9.15B8.01B7.47B8.21B9.61B
Revenue Growth
20.03%9.75%-12.43%-6.79%9.95%17.02%
Gross Profit
6.25B7.04B6.08B5.42B5.87B6.95B
Gross Margin
74.93%76.89%75.82%72.60%71.50%72.35%
Operating Income
3.15B3.55B2.71B1.65B1.58B2.13B
Net Income
3.02B3.26B2.40B1.62B1.49B2.00B
EPS
----0.730.87
EPS Growth
----3.94%18.56%
Forward PE
7.977.718.908.7714.8110.76
Dividend / Share
0.490.530.390.270.290.36
Dividend Growth
18.66%8.84%-26.70%-31.56%8.95%23.40%
Free Cash Flow
1.35B2.09B1.55B544.94M212.65M1.46B
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High9.7B
Avg9.6B
Low9.5B

Revenue Growth

Revenue Growth202620272028
High
18.1%
Avg
17.0%
Low
15.2%

EPS Forecast

EPS202620272028
High0.87
Avg0.87
Low0.87

EPS Growth

EPS Growth202620272028
High
18.6%
Avg
18.6%
Low
18.6%